Category - Executive Moves

Executive Moves

Oppenheimer expands healthcare investment banking team

Oppenheimer (NYSE:OPY) continued to build out its healthcare leadership team, adding three members to its healthcare investment banking team: Jonathan Fassberg, in the newly created role of vice chairman; Brian Korb, as...

March 24, 2021

Executive Moves

KA Imaging adds world renowned radiologist Philip Templeton as CMO

X-ray manufacturer, KA Imaging, appointed Dr. Philip Templeton, M.D., to the newly created position of chief medical officer (CMO). A board certified radiologist, Dr. Templeton brings over 38 years of academic and...

March 8, 2021

Executive Moves

Medtech analyst Raj Denhoy joins Establishment Labs as head of strategy, IR

Establishment Labs Holdings (NASDAQ: ESTA) appointed Raj Denhoy as head of strategy and investor relations to help define and execute the company’s corporate strategy and communicate that vision to investors and other...

March 3, 2021

Executive Moves

Profound Medical appoints healthcare investment professional Cynthia Lavoie to board

Profound Medical (NASDAQ:PROF; TSX:PRN) appointed seasoned healthcare investment professional Cynthia Lavoie, Ph.D., to the board of the commercial-stage medical device company that develops and markets customizable...

March 3, 2021

Executive Moves

Nurx names telehealth pioneer Jennifer Peña as CMO

Nurx, a telehealth platform providing convenient and affordable care for female health needs, appointed Dr. Jennifer Peña, M.D., as chief medical officer to help Nurx build on a record year of growth and begin treating...

March 1, 2021

Executive Moves

PYC Therapeutics adds industry veteran Glenn Noronha as CDO

Glenn Noronha Glenn Noronha, PhD, has joined PYC Therapeutics (ASX:PYC) as chief development officer to oversee the company’s translational clinical development, regulatory, manufacturing and preclinical development...

February 23, 2021

Executive Moves

iBio appoints accomplished financial executive Robert Lutz as CFBO

Robert Lutz iBio (NYSE American:iBio) appointed Robert Lutz as chief financial and business officer (CFBO), effective March 4, 2021. Mr. Lutz will lead iBio’s finance organization and be responsible for building strong...

February 16, 2021

Executive Moves

Hepion names renowned clinician Dr. Todd Hobbs as CMO

Todd Hobbs Hepion Pharmaceuticals (NASDAQ:HEPA) appointed Todd Hobbs, M.D., to the newly created position of chief medical officer, effective Feb. 16, 2021. In this role, Dr. Hobbs will help lead Hepion as it engages...

February 10, 2021

Executive Moves

PharmaJet names Marian Wentworth to board

Marian Wentworth Closely-held PharmaJet appointed Marian Wentworth, president and CEO of Management Sciences for Health since 2017, to its board. Management Sciences for Health is a non-profit organization that works...

February 9, 2021

Executive Moves

Jim Lilly joins England & Co. in healthcare investment banking

Jim Lilly Jim Lilly joined England & Co., a middle-market investment bank, as a managing director in its New York office. Mr. Lilly brings more than 30 years of experience as a strategic advisor to a wide variety of...

January 19, 2021

Category - Executive Moves

Oppenheimer expands healthcare investment banking team

KA Imaging adds world renowned radiologist Philip Templeton as CMO

Medtech analyst Raj Denhoy joins Establishment Labs as head of strategy, IR

Profound Medical appoints healthcare investment professional Cynthia Lavoie to board

Nurx names telehealth pioneer Jennifer Peña as CMO

PYC Therapeutics adds industry veteran Glenn Noronha as CDO

iBio appoints accomplished financial executive Robert Lutz as CFBO

Hepion names renowned clinician Dr. Todd Hobbs as CMO

PharmaJet names Marian Wentworth to board

Jim Lilly joins England & Co. in healthcare investment banking

General

More